Last reviewed · How we verify
NCT06794346
Sexual Effects of Transdermal or Vaginal Testosterone
Phase 2 trial testing Transdermal testosterone in Female Sexual Dysfunction in 132 participants. Participants enrolled and being followed up; not accepting new ones.
1 October 2024
Quick facts
| Lead sponsor | University of Sao Paulo General Hospital |
|---|---|
| Phase | Phase 2 |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 132 |
| Start date | 1 October 2020 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 November 2025 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Transdermal testosterone — full drug profile →
- Vaginal testosterone gel — full drug profile →
- Placebo group
Conditions studied
- Female Sexual Dysfunction — all drugs for Female Sexual Dysfunction →
- Postmenopausal Symptoms — all drugs for Postmenopausal Symptoms →
- Testosterone Deficiency — all drugs for Testosterone Deficiency →
- Testosterone Adverse Reaction — all drugs for Testosterone Adverse Reaction →
Sponsor
University of Sao Paulo General Hospital
Who can join
Adults 38 to 60, female only, with Female Sexual Dysfunction or Postmenopausal Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to elucidate the role of testosterone treatment in postmenopausal women's sexual function and their therapeutic safety.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06794346
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Female Sexual Dysfunction
Currently open trials in the same condition.
- NCT06729151 — Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patient · recruiting
- NCT06116045 — Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder · Phase 2 · recruiting
Other University of Sao Paulo General Hospital trials
Trials by the same sponsor.
- NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07478094 — Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost · not yet recruiting
- NCT07341386 — Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07242092 — Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs · Phase 4 · not yet recruiting
- NCT07484152 — Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06794346 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo General Hospital
- Last refreshed: 27 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06794346.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing